Efficacy and Safety of Basal Insulin in Type 2 Diabetes

PROGRAM DESCRIPTION Insulin is often required in many patients with type 2 diabetes mellitus because of disease progression and the loss of pancreatic β-cell insulin secretion. Ideally, exogenously administered insulin ...

PROGRAM DESCRIPTION
Insulin is often required in many patients with type 2 diabetes mellitus because of disease progression and the loss of pancreatic β-cell insulin secretion. Ideally, exogenously administered insulin mimics the physiologic profile of endogenous insulin secretion in healthy persons. New insulin formulations have been developed to improve the physiologic profile in patients with diabetes, which may decrease the risk of hypoglycemia and weight gain. In this online educational activity, the faculty sets the stage for the second module in the series by reviewing the efficacy and safety of basal insulin in managing type 2 diabetes, focusing on newer insulin therapies. Evidence from clinical trials supporting glycemic and cardiovascular benefits of diabetes therapies is reviewed, and the clinical profiles of different insulin products are compared with respect to dosing, variability, volume, and safety.

EDUCATIONAL OBJECTIVES
At the conclusion of this application-based educational activity, participants should be able to:Review recent clinical trial results supporting the potential for positive glycemic and cardiovascular benefits of diabetes therapiesCompare the pharmacokinetics and pharmacodynamics of newer basal insulin formulations with older formulationsCompare the clinical profiles of currently available basal insulin products with respect to dosing, variability, volume, and safety

---

Write the first review

Resource tags